DUBLIN, July 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Cell Culture Market by Equipment, by Reagent, by Application - Global Forecast to 2018" report to their offering.
Biopharmaceuticals are pharmaceutical products isolated from living organisms. Cell culture is one of the most important and widely used techniques for biopharmaceutical production. It was also the largest application segment of the cell culture market in 2013. Growth in the biopharmaceutical market will drive the growth of the cell culture market. The global cell culture market was valued at $ 14,772 million in 2013 and is poised to grow at a CAGR of 10.71% between 2013 and 2018, to reach $24,574 million in 2018.
Rapid increase in biopharmaceutical production and increasing healthcare expenditure will be the two most important growth drivers for this market in the forecast period from 2013 to 2018. Biopharmaceutical production had the largest share of the cell culture market in 2013. According to IMS Health, biopharmaceutical is expected to one of the fastest growing pharmaceutical segment between 2012 and 2017. The increasing demand for biopharmaceutical products like vaccines and antibodies coupled with strong pipelines for biopharmaceuticals and increasing healthcare expenditure will drive the demand for cell culture products.
The global cell culture market comprises of cell culture equipment and cell culture media, sera, and reagent markets. The cell culture equipment market consists of five equipment segments, namely, lab equipment, bio-safety cabinets, consumables, storage equipment, and sterilization equipment. The cell culture media, sera, and reagents market consists of six segments, namely, serum, media, lab reagents, contamination detection kits, cryoprotective agents, and other reagents.
The application segments included in this report are biopharmaceutical production, tissue culture and engineering, vaccine production, drug screening and development, gene therapy, toxicity testing, cancer research, and other applications. The biopharmaceutical application segment had the largest share of the cell culture market in 2013, owing to the large demand for cell culture sera, media, and reagents for biopharmaceutical production.
This report segments the cell culture market into two distinct market segments, namely, the cell culture equipment market and the cell culture media, sera, and reagents market. The segments of the cell culture equipment market included in this report are; bio-safety cabinets, consumables, lab equipment, sterilization equipment, and storage equipment. The lab equipment segment consists of four subsegments, namely, cell counters, centrifuges, fermentors and bioreactors, and incubators. The storage equipment segment consists of two subsegments, namely, cryogenic storage and refrigerators and freezers.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Cell Culture Equipment Market
5 Cell Culture Media, Sera & Reagents Market
6 Cell Culture Market, By Applications
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles
- Becton, Dickinson and Company
- Corning, Inc.
- Eppendorf AG
- Lonza Group Ltd.
- Merck Kgaa
- Promocell GMBH
- Sartorius AG
- Sigma-Aldrich Corporation
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/4nkgwr/cell_culture
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets